These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22992142

  • 1. Multiple sclerosis treatment: current best practice.
    Niino M.
    Expert Rev Clin Immunol; 2012 Aug; 8(6):505-7. PubMed ID: 22992142
    [No Abstract] [Full Text] [Related]

  • 2. [Multiple sclerosis, the therapeutic arsenal of today and tomorrow].
    Zéphir H.
    Soins; 2009 Nov; (740):39-41. PubMed ID: 20014532
    [No Abstract] [Full Text] [Related]

  • 3. A practical guide to pediatric multiple sclerosis.
    Huppke P, Gärtner J.
    Neuropediatrics; 2010 Aug; 41(4):157-62. PubMed ID: 21086219
    [Abstract] [Full Text] [Related]

  • 4. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J, Lublin FD.
    Adv Neurol; 2006 Aug; 98():257-71. PubMed ID: 16400838
    [No Abstract] [Full Text] [Related]

  • 5. Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice.
    Costello F, Stüve O, Weber MS, Zamvil SS, Frohman E.
    Curr Opin Neurol; 2007 Jun; 20(3):281-5. PubMed ID: 17495621
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacological treatment of multiple sclerosis].
    Myhr KM.
    Tidsskr Nor Laegeforen; 2010 Mar 11; 130(5):490-2. PubMed ID: 20224616
    [Abstract] [Full Text] [Related]

  • 7. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM, Rainka MM, Patel MJ, Gengo FM.
    Pharmacotherapy; 2010 Sep 11; 30(9):916-27. PubMed ID: 20795847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group].
    Sellebjerg FT, Sørensen PS, Dansk Selskab for Forskning i Multipel Sclerose og Dansk Multipel Sclerose Gruppe.
    Ugeskr Laeger; 2007 Mar 19; 169(12):1121. PubMed ID: 17394832
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis.
    Banwell B, Tremlett H.
    Neurology; 2005 Mar 08; 64(5):778-9. PubMed ID: 15753408
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The RESTORE trial: what did we learn about multiple sclerosis?
    Karceski S.
    Neurology; 2014 Apr 29; 82(17):e155-7. PubMed ID: 24778292
    [No Abstract] [Full Text] [Related]

  • 17. Treatment and treatment trials in multiple sclerosis.
    Kieseier BC, Wiendl H, Hemmer B, Hartung HP.
    Curr Opin Neurol; 2007 Jun 29; 20(3):286-93. PubMed ID: 17495622
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Current immunotherapy of multiple sclerosis].
    Paul F, Ruprecht K.
    Nervenarzt; 2015 Aug 29; 86(8):1031-42; quiz 1043-4. PubMed ID: 26253589
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.